We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 572

CMS issues changes to IDTF enrollment rules - block leasing and other shared imaging arrangements may need restructuring

  • McDermott Will & Emery
  • -
  • USA
  • -
  • February 13 2007

On January 26, 2007, the Centers for Medicare and Medicaid Services (CMS) issued guidance that could have a significant impact on independent diagnostic testing facilities (IDTFs) and those physician practices, hospitals and other providers doing business with them

Congress approves Medicare, Medicaid, SCHIP changes

  • McDermott Will & Emery
  • -
  • USA
  • -
  • December 28 2007

In one of its final acts before adjourning for the year, Congress approved a modest bill (S.2499) that averts a 10.1 percent reduction in Medicare payments to physicians, extends the State Children’s Health Insurance Program (SCHIP) that provides health insurance to millions of low-income children, and makes various other changes that provide payment and regulatory relief to dozens of other Medicare and Medicaid stakeholders

The American Taxpayer Relief Act of 2012 and anticipated Medicare and Medicaid payment reforms

  • McDermott Will & Emery
  • -
  • USA
  • -
  • January 8 2013

On January 1, 2013, the U.S. Congress approved the American Taxpayer Relief Act of 2012 (the Act), concluding a protracted debate on how to prevent the

2009 Medicare physician fee schedule

  • McDermott Will & Emery
  • -
  • USA
  • -
  • July 16 2008

The proposed 2009 Medicare physician fee schedule (MPFS) regulations published in the Federal Register on July 7, 2008, cover a wide range of topics that affect not just physician compensation, but also the manner in which physicians may provide and be paid for services other than traditional professional services

IRS issues miscellaneous guidance on health savings accounts

  • McDermott Will & Emery
  • -
  • USA
  • -
  • July 18 2008

In 2003, the Medicare Prescription Drug, Improvement, and Modernization Act added Section 223 to the Internal Revenue Code (Code), permitting eligible individuals to establish Health Savings Accounts (HSAs

Deregulation of the German health care service sector opens investment opportunities

  • McDermott Will & Emery
  • -
  • Germany
  • -
  • February 26 2007

The German health care market is in flux

Commission investigates pharmaceutical sector for anti-competitive practices

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • January 18 2008

The European Commission has launched a sector inquiry with a series of on-the-spot competition investigations into pharmaceutical companies

EPO Enlarged Board of Appeal invites the public to determine whether stem cells are contrary to morality

  • McDermott Will & Emery
  • -
  • European Union
  • -
  • July 30 2008

On 24 and 25 June 2008, in a public hearing on Wisconsin Alumni Research Foundation (WARF) Stem Cell patent application (G-0206), the European Patent Office (EPO) took the usual step of asking the public to assist it in making a determination regarding a patent application involving an invention in the controversial area of stem cell patenting

Reverse doctrine of equivalents remains unsuccessful

  • McDermott Will & Emery
  • -
  • USA
  • -
  • July 30 2008

Finding no error in the district court’s holding that the reverse doctrine of equivalents was inapplicable and that claim preclusion prohibited the defendant from raising other validity challenges, the U.S. Court of Appeals for the Federal Circuit affirmed a district court’s finding of patent validity and infringement

Commission authorises reform of Belgian tax

  • McDermott Will & Emery
  • -
  • Belgium, European Union
  • -
  • February 1 2008

In Belgium pharmaceutical companies contribute to the financing of the health system through a tax calculated on the basis of sales of reimbursed medicines